Kayexalate

Active Ingredient(s): Sodium Polystyrene Sulfonate
FDA Approved: * June 5, 1958
Pharm Company: * SANOFI AVENTIS US
Category: Potassium Levels

Polystyrene sulfonates are a group of medications used to treat high blood potassium.[1] Effects generally take hours to days.[1] They are also used to remove potassium, calcium, and sodium from solutions in technical applications. Common side effects include loss of appetite, gastrointestinal upset, constipation, and low blood calcium.[1] These polymers are derived from polystyrene by the addition of sulfonate functional groups. Sodium polystyr... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Kayexalate 4.1 Meq/G Oral; Rectal Powder, for Suspension
NDC: 24987-075
Labeler:
Covis Pharmaceuticals, Inc.
Kayexalate 4.1 Meq/G Oral; Rectal Powder, for Suspension
NDC: 59212-075
Labeler:
Concordia Pharmaceuticals Inc.

Related Brands

Drugs with the same active ingredients